Compelling experimental evidence suggests that microglial activation is involved in the spread
of tau tangles over the neocortex in Alzheimer’s disease (AD). We tested the hypothesis …

Whilst cerebrospinal fluid (CSF) and positron emission tomography (PET) biomarkers for
amyloid-β (Aβ) and tau pathologies are accurate for the diagnosis of Alzheimer’s disease (AD), …

Alzheimer’s disease biomarkers are primarily evaluated through MRI, PET and CSF methods
in order to diagnose and monitor disease. Recently, advances in the assessment of blood-…

The clinical and pathophysiological correlates of locus coeruleus (LC) degeneration in
Alzheimer’s disease (AD) could be clarified using a method to index LC integrity in vivo, …

Braak stages of tau neurofibrillary tangle accumulation have been incorporated in the
criteria for the neuropathological diagnosis of Alzheimer’s disease. It is expected that Braak …

Importance Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that
increases in the cerebrospinal fluid (CSF) and blood of individuals with Alzheimer disease (AD). …

An unresolved question for the understanding of Alzheimer’s disease (AD) pathophysiology
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …

Importance Apolipoprotein E ε4 (APOEε4) is the single most important genetic risk factor for
Alzheimer disease. WhileAPOEε4is associated with increased amyloid-β burden, its …

Gold-standard diagnosis of Alzheimer’s disease (AD) relies on histopathological staging
systems. Using the topographical information from [ 18 F]MK6240 tau positron-emission …

Importance The recent proliferation of phosphorylated tau (p-tau) biomarkers has raised
questions about their preferential association with the hallmark pathologies of Alzheimer …